304 related articles for article (PubMed ID: 1583176)
21. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
23. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
24. The significance of tumor persistence after incomplete excision of basal cell carcinoma.
Berlin J; Katz KH; Helm KF; Maloney ME
J Am Acad Dermatol; 2002 Apr; 46(4):549-53. PubMed ID: 11907506
[TBL] [Abstract][Full Text] [Related]
25. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
26. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
27. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
28. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
29. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography for margin definition of basal cell carcinoma before micrographic surgery-recommendations regarding the marking and scanning technique.
De Carvalho N; Schuh S; Kindermann N; Kästle R; Holmes J; Welzel J
Skin Res Technol; 2018 Feb; 24(1):145-151. PubMed ID: 29057513
[TBL] [Abstract][Full Text] [Related]
31. Management of Incompletely Excised Skin Tumors: Our Experience.
Robertson BF; Wokes JET; Siddiqui H
Dermatol Surg; 2018 Mar; 44(3):365-369. PubMed ID: 29053539
[TBL] [Abstract][Full Text] [Related]
32. Mohs surgery of basal cell carcinoma--a critical review.
Lawrence CM
Br J Plast Surg; 1993 Oct; 46(7):599-606. PubMed ID: 8252270
[TBL] [Abstract][Full Text] [Related]
33. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of non-melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery.
Queen D; Knackstedt T; Polacco MA; Collins LK; Lee K; Samie FH
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):305-311. PubMed ID: 30284728
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors.
Chu J; Chung Y; Chae SW; Choi YJ; Kim HS; DO SI
Anticancer Res; 2023 Jun; 43(6):2707-2715. PubMed ID: 37247935
[TBL] [Abstract][Full Text] [Related]
36. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions.
Dika E; Veronesi G; Patrizi A; De Salvo S; Misciali C; Baraldi C; Mussi M; Fabbri E; Tartari F; Lambertini M
Dermatol Ther; 2020 Jul; 33(4):e13474. PubMed ID: 32391961
[TBL] [Abstract][Full Text] [Related]
37. Periocular basal cell carcinoma recurrence following surgical treatment: Safe surveillance time.
Juniat V; Shah P; Vonica O; Daniel CS; Murta F
Eye (Lond); 2023 Apr; 37(5):971-976. PubMed ID: 35804019
[TBL] [Abstract][Full Text] [Related]
38. Confident complete excision of lid-margin BCCs using a marginal strip: an alternative to Mohs' surgery.
Dhingra N; Gajdasty A; Neal JW; Mukherjee AN; Lane CM
Br J Ophthalmol; 2007 Jun; 91(6):794-6. PubMed ID: 17229804
[TBL] [Abstract][Full Text] [Related]
39. Dermoscopy-guided Mohs micrographic surgery in post-laser basal cell carcinomas: is dermoscopy helpful for demarcation of the surgical margin?
Shin K; Kim HJ; Ko HC; Kim BS; Kim MB; Kim HS
J Dermatolog Treat; 2022 Feb; 33(1):433-436. PubMed ID: 32345116
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
